Published By James Quinn, Daily Telegraph, 26 Oct 2009
Save for the economy, in the first year of Barack Obama’s presidency the issue he has spent the most time on has also been the most contentious – the future of healthcare.
As he tries to right the failings of several of his predecessors, the US president’s push to increase healthcare provision for the 20pc of Americans without health insurance – at the same time as not overly increasing the burden on taxpayers – is a difficult task.
With the US budget deficit at $1.42 trillion, the $829m (£506m), ten-year cost of the Senate finance committee’s bill – the main one of five pieces of legislation President Obama is to attempt to meld together in the coming weeks – may just be too much to bear.
Whatever the outcome, however, it is clear that the $2.3 trillion-a-year US healthcare industry offers significant opportunities to make money.
For British companies, the sheer breadth of the market – with its regionalised approach and the power of private medical insurance companies – might be unnerving, but in fact offers clear advantages, as Nottingham, UK based Design Cognition hope to capitalise on over the coming weeks as part of a UK Trade & Investment (UKTI) “mission” to the American Association of Pharmaceutical Scientists (AAPS) in November.
If you are a company that want to launch your pharma products into new markets but are confused by packaging requirements & regulations, find out more about how Design Cognition can help at www.thepharmagateway.com
Design Cognition is also looking for individuals /companies that can provide collaborative support ‘on the ground’ in the US to help facilitate entry into the US pharma market. For further details contact Chris Penfold, Chief Executive.
You can read the full Daily Telegraph article here: http://tinyurl.com/yg2pkoc
